A detailed history of Jackson Hole Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 34,150 shares of ABBV stock, worth $5.86 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
34,150
Previous 34,150 -0.0%
Holding current value
$5.86 Million
Previous $5.86 Million 15.13%
% of portfolio
1.43%
Previous 1.29%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $292,553 - $341,636
1,890 Added 5.86%
34,150 $5.86 Million
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $299,183 - $340,891
-1,872 Reduced 5.48%
32,260 $5.87 Million
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $240,662 - $271,042
1,749 Added 5.4%
34,132 $5.29 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $134,257 - $155,423
-1,005 Reduced 3.01%
32,383 $4.83 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $40,283 - $50,129
304 Added 0.92%
33,388 $4.5 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $92,695 - $106,752
-641 Reduced 1.9%
33,084 $5.27 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $38,035 - $45,614
-275 Reduced 0.81%
33,725 $5.45 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $78,781 - $90,356
587 Added 1.76%
34,000 $4.56 Million
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $12,385 - $15,746
90 Added 0.27%
33,413 $5.12 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $34,578 - $42,902
-262 Reduced 0.78%
33,323 $5.4 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $212,066 - $268,325
1,974 Added 6.24%
33,585 $4.55 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $508,060 - $576,724
4,775 Added 17.79%
31,611 $3.41 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $451,456 - $502,948
4,291 Added 19.03%
26,836 $3.02 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $380,351 - $418,721
3,718 Added 19.75%
22,545 $2.44 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $62,299 - $84,110
774 Added 4.29%
18,827 $2.02 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $36,855 - $43,256
429 Added 2.43%
18,053 $1.58 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $37,638 - $50,366
513 Added 3.0%
17,624 $1.73 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $127,194 - $192,841
1,972 Added 13.03%
17,111 $1.3 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $346,893 - $417,065
5,508 Added 57.19%
15,139 $1.15 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $191,909 - $245,305
2,921 Added 43.53%
9,631 $700,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $48,058 - $56,562
623 Added 10.23%
6,710 $541,000
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $473,872 - $584,412
6,087 New
6,087 $561,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jackson Hole Capital Partners, LLC Portfolio

Follow Jackson Hole Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.